首页|期刊导航|Genes & Diseases|PANDORA-seq reveals human sperm sncRNA signature endowed with sperm quality assessment

PANDORA-seq reveals human sperm sncRNA signature endowed with sperm quality assessmentOA

中文摘要

One of the leading causes of human subfertility is the continuous decline in semen quality,contributing to a global fertility crisis.Over half of subfertile men suffer from asthenozoospermia and teratozoospermia,with mechanisms still largely unknown.Traditional small noncoding RNA sequencing(sncRNA-seq)primarily targets miRNAs,failing to capture the broader spectrum of small noncoding RNAs(sncRNAs),including abundant transfer RNA-derived small RNAs(tsRNAs)and ribosomal RNA-derived small RNAs(rsRNAs).These sncRNAs possess complex RNA modifications and non-canonical terminal structures,impeding their accurate profiling.In this prospective cohort study,we addressed these limitations by combining our state-of-the-art PANDORA-seq with traditional sncRNA-seq,which generated the most comprehensive sncRNA landscape of human sperm from 25 participants with asthenozoospermia,teratozoospermia,or normozoospermia.PANDORA-seq significantly improved the annotation efficiency of sncRNAs and delivered a more detailed characterization for tsRNAs and rsRNAs,which were strongly correlated with key clinical indicators of sperm quality,thereby enhancing our understanding of the landscape of human sperm sncRNAome and its association with male subfertility.Importantly,machine learning with Lasso regression identified specific tsRNA/rsRNA signatures as highly effective clinical biomarkers(AUC≥0.83)for predicting sperm abnormalities,offering significant improvements over World Health Organization-based semen quality assessments and novel insights for clinical diagnosis.

Ruofan Huang;Yiting Yang;Wenlin Jiang;Zheng Cao;Junchao Shi;Xiao-Ou Zhang;Yunfang Zhang

Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital,Shanghai Key Laboratory of Signaling and Disease Research,Frontier Science Center for Stem Cell Research,School of Life Sciences and Technology,Tongji University,Shanghai 200092,ChinaClinical and Translational Research Center of Shanghai First Maternity and Infant Hospital,Shanghai Key Laboratory of Signaling and Disease Research,Frontier Science Center for Stem Cell Research,School of Life Sciences and Technology,Tongji University,Shanghai 200092,China NHC Key Lab of Reproduction Regulation,Shanghai-MOST Key Laboratory of Health and DiseaseGenomics,Shanghai Institute for Biomedical and Pharmaceutical Technologies(SIBPT),Shanghai 200032,ChinaClinical and Translational Research Center of Shanghai First Maternity and Infant Hospital,Shanghai Key Laboratory of Signaling and Disease Research,Frontier Science Center for Stem Cell Research,School of Life Sciences and Technology,Tongji University,Shanghai 200092,ChinaClinical and Translational Research Center of Shanghai First Maternity and Infant Hospital,Shanghai Key Laboratory of Signaling and Disease Research,Frontier Science Center for Stem Cell Research,School of Life Sciences and Technology,Tongji University,Shanghai 200092,ChinaChina National Center for Bioinformation and Beijing Institute of Genomics,Chinese Academy ofSciences,Beijing 100101,ChinaClinical and Translational Research Center of Shanghai First Maternity and Infant Hospital,Shanghai Key Laboratory of Signaling and Disease Research,Frontier Science Center for Stem Cell Research,School of Life Sciences and Technology,Tongji University,Shanghai 200092,ChinaClinical and Translational Research Center of Shanghai First Maternity and Infant Hospital,Shanghai Key Laboratory of Signaling and Disease Research,Frontier Science Center for Stem Cell Research,School of Life Sciences and Technology,Tongji University,Shanghai 200092,China

医药卫生

Male subfertilityPANDORA-seqrsRNASperm qualitytsRNA

《Genes & Diseases》 2026 (4)

P.663-676,14

supported by the National Key Research and Development Program of China(No.2019YFA0802600 to Y.F.Z.,2022YFA1103200 to X.O.Z.)the National Natural Science Foundation of China(No.82371727,82022029,81971460 toY.F.Z.,32170553 to X.O.Z.,32370596 to J.C.S.)Science and Technology Commission of Shanghai Municipality,China(No.23JC1403802 to Y.F.Z.)Innovation Promotion Program of NHC and Shanghai Key Labs,SIBPT(China)(No.RC2024-04 toY.T.Y.)Strategic Priority Research Program of the ChineseAcademy of Sciences(No.XDA0460302 to J.C.S.)Fundamental Research Funds for the Central Universities of China(No.22120240435 to Y.F.Z.and X.O.Z.).The NationalKey Research and Development Program of China providesthe funding for the open access charge.

10.1016/j.gendis.2025.101807

评论